February 27, 2017
JPA President Nobuo Yamamoto Three major pharmacy/pharmacist organizations will draw up guidelines on inter-pharmacy drug transactions in the wake of the counterfeit Harvoni (ledipasvir + sofosbuvir) issue , aiming to announce them within this fiscal year, which will end in...read more